Access to this full-text is provided by PLOS.
Content available from PLOS One
This content is subject to copyright.
RESEARCH ARTICLE
Prevalence of multidrug-resistant organisms
in nursing homes in Belgium in 2015
Katrien LatourID
1,2☯
*, Te-Din Huang
3☯
, Be
´atrice Jans
1
, Catherine Berhin
3
,
Pierre Bogaerts
3
, Audrey Noel
3
, Claire Nonhoff
4
, Magali Dode
´mont
4
, Olivier Denis
5
,
Margareta Ieven
6
, Katherine Loens
6
, Didier Schoevaerdts
7,8
, Boudewijn Catry
1,5
,
Youri Glupczynski
3
1Operational Directorate Epidemiology & Public Health, Sciensano, Brussels, Belgium, 2Department of
Public Health and Primary Care, University of Leuven, Leuven, Belgium, 3National Reference Centre for
antibiotic resistant Gram-negative bacilli, Laboratory of Clinical Microbiology, Centre hospitalier universitaire
de Namur, Universite
´catholique de Louvain, Yvoir, Belgium, 4National Reference Centre for methicillin-
resistant Staphylococcus aureus and staphylococci, Department of Clinical Microbiology, Ho
ˆpital Erasme,
Universite
´Libre de Bruxelles, Brussels, Belgium, 5Ecole de Sante
´Publique, Universite
´Libre de Bruxelles,
Brussels, Belgium, 6National Reference Centre for vancomycin-resistant enterococci, Department of Clinical
Microbiology, University Hospital of Antwerp, Edegem, Belgium, 7Department of Geriatric Medicine, Centre
hospitalier universitaire de Namur, Universite
´catholique de Louvain, Mont-Godinne, Belgium, 8Institute of
Health and Society, Ecole de Sante
´Publique, Universite
´catholique de Louvain, Brussels, Belgium
☯These authors contributed equally to this work.
*katrien.latour@sciensano.be
Abstract
Objectives
Following two studies conducted in 2005 and 2011, a third prevalence survey of multidrug-
resistant microorganisms (MDRO) was organised in Belgian nursing homes (NHs) using a
similar methodology. The aim was to measure the prevalence of carriage of methicillin-resis-
tant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), extended-
spectrum β-lactamase producing Enterobacteriaceae (ESBLE) and carbapenemase-pro-
ducing Enterobacteriaceae (CPE) in NH residents. Risk factors for MDRO carriage were
also explored.
Methods
Up to 51 randomly selected residents per NH were screened for MDRO carriage by trained
local nurses between June and October 2015. Rectal swabs were cultured for ESBLE, CPE
and VRE, while pooled samples of nose, throat and perineum and chronic wound swabs
were obtained for culture of MRSA. Antimicrobial susceptibility testing, molecular detection
of resistance genes and strain genotyping were performed. Significant risk factors for
MDRO colonization MDRO was determined by univariate and multivariable analysis.
Results
Overall, 1447 residents from 29 NHs were enrolled. The mean weighted prevalence of
ESBLE and MRSA colonization was 11.3% and 9.0%, respectively. Co-colonization
occurred in 1.8% of the residents. VRE and CPE carriage were identified in only one
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 1 / 18
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Latour K, Huang T-D, Jans B, Berhin C,
Bogaerts P, Noel A, et al. (2019) Prevalence of
multidrug-resistant organisms in nursing homes in
Belgium in 2015. PLoS ONE 14(3): e0214327.
https://doi.org/10.1371/journal.pone.0214327
Editor: Jan Kluytmans, Amphia Ziekenhuis,
NETHERLANDS
Received: February 13, 2019
Accepted: March 11, 2019
Published: March 28, 2019
Copyright: ©2019 Latour et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data cannot be
shared publicly because of ethical reasons and
protection of personal data. Our patients did not
consent to make their data public available and the
informed consent mentioned that access to the
data can only take place under the supervision of
the principal investigator or one of his
collaborators. For these reasons, data excerpts
from the MDRO 2015 nursing home study are (in
the absence of a Data Access Committee) only
available on request to the authors (nsih-
info@sciensano.be). Formal written requests
should include following information: (1) name,
resident each. Impaired mobility and recent treatment with fluoroquinolones or with combi-
nations of sulphonamides and trimethoprim were identified as risk factors for ESBLE car-
riage, while for MRSA these were previous MRSA carriage/infection, a stay in several
different hospital wards during the past year, and a recent treatment with nitrofuran deriva-
tives. Current antacid use was a predictor for both ESBL and MRSA carriage.
Conclusions
In line with the evolution of MRSA and ESBL colonization/infection in hospitals, a decline in
MRSA carriage and an increase in ESBLE prevalence was seen in Belgian NHs between
2005 and 2015. These results show that a systemic approach, including surveillance and
enhancement of infection control and antimicrobial stewardship programs is needed in both
acute and chronic care facilities.
Introduction
The increasing prevalence of infections due to multidrug-resistant organisms (MDROs) repre-
sents a worldwide public health problem and is not only of importance in acute care hospitals
[1]. Long-term care facilities (LTCFs), such as nursing homes (NHs), have been identified as
important reservoirs of methicillin-resistant Staphylococcus aureus (MRSA) and extended-
spectrum β-lactamase producing Enterobacteriaceae (ESBLE) by prevalence and incidence
studies conducted in different European countries [2]. Recently, there have also been several
reports of infection and/or colonization by other MDROs like carbapenemase-producing
Enterobacteriaceae (CPE) and vancomycin-resistant enterococci (VRE) among its residents
[3–15].
In many ways, LTCFs and NHs are favourable settings for the emergence and spread of
antimicrobial resistance (AMR) over the healthcare network. These facilities outnumber acute
care hospitals in numbers and total number of beds and although these facilities provide less
specialized care and therefore have a lower daily probability of transmission of antimicrobial
resistant pathogens, the spread can be more effective because of the much longer length of stay
of the LTCF residents [16,17]. In addition, these facilities often strive to create a homelike envi-
ronment. Infection prevention and control (IPC) guidelines are less stringent in NHs and ade-
quately trained IPC personnel is often lacking [18,19]. Diagnostic uncertainty due to limited
access to laboratory tests, sampling difficulties and atypical presentation of illness in frail older
adults can lead to overuse of antibiotics and prolonged empirical therapy, which in turn poten-
tially increase selection pressure on bacteria to become resistant [16,18,20]. Last but not least,
frequent transfers of infected or colonized patients can lead to the diffusion of MDROs inside
of and between acute care facilities and LTCFs [16,17,21].
Two cross-sectional surveys conducted in 2005 and 2011 in 60 Belgian different NHs
showed that 19.5% and 12.2% of the screened residents were asymptomatic carriers of MRSA,
respectively [22,23]. The 2011 survey also found that 6.2% of the residents were colonized with
ESBLE and that none carried VRE. Carriage of CPE was at that time not explored [23].
At the end of 2011, the Superior Health Council of Belgium published an advice for the
detection, prevention and control of CPE in Belgium, soon after the National Reference Centre
for antibiotic resistant Gram-negative bacilli had noticed a rise in the number of cases [24]. A
national surveillance program, combining epidemiological and microbiological data, was set
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 2 / 18
organisation, contact details and CV of the
applicant, (2) names of all individual researchers
that will work on the data, (3) outline of the
research for which the data is requested, (4) data
analysis plan, and (5) planned end date of the
research. Requests will be evaluated against
following criteria: (1) the scientific quality of the
proposal, and (2) whether the scope of the data
request is consonant with the scope of the
scientific project in which the data were collected.
The data set may be used only for the purpose
stipulated in the request and only by the requesting
party. The data may not be passed on to or shared
with a third party. The data may be used only for
the time period agreed upon. Those granted access
are required to sign a statement indicating their
agreement with all policies prior to being allowed
access to the data. Any publication must cite the
source of data.
Funding: This study was organized with the
support of the Belgian Antibiotic Policy
Coordination Committee. The funder had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
up and results showed a significant increase in the number of CPE cases reported by different
hospital laboratories. CPE strains were no longer only found in patients repatriated from
abroad, but also in patients without any travel history and most were admitted to geriatric
departments [25]. An American study identified transfer from high-acuity LTCFs to be associ-
ated with carriage of CPE upon hospital admission [26]. Although nursing homes in Belgium
are less medicalized and serve as a home-like environment where residents in general stay
until their end of life, we were interested in knowing the prevalence of CPE carriage in these
facilities. Using a methodology comparable to the 2011 survey, we conducted a national preva-
lence study in 2015 to explore the asymptomatic carriage rate of CPE in addition to MRSA,
ESBLE, and VRE.
The aim of the present paper is to present the prevalence of asymptomatic carriage of
MRSA, ESBLE, CPE, and VRE found during the 2015 survey in Belgian NH residents. More-
over, risk factors associated with carriage of these MDRO are described.
Materials and methods
Study design
A cross-sectional prevalence survey was organised between June and October 2015. Thirty
NHs (and two reserve facilities per selected NH) were systematically selected from the national
insurance database, which was sorted according to region, NH size and proportion of high-
care beds. An invitation to participate in the study was sent by regular mail to the director and
coordinating physician of these facilities and all NHs were contacted by phone. In case of
refusal of the primary selected NHs and its two substitutions, a NH from outside the initial
selection was recruited by phone (active/selected recruitment). Preference was given to NHs
with characteristics as close as possible to the primary selected NH, i.e. same regional distribu-
tion, NH size and proportion of high-care beds.
According to a previously described methodology the study coordinating team selected at
random up to 51 residents (and 10 reserve) in each participating NH [22,23]. These residents
had to be screened for MDRO carriage on one single day. In addition, if applicable, all room-
mates of selected residents had to be screened as well.
Data collection
The study within the NH was coordinated by a local reference nurse and/or by the coordinating
physician of the facility. This local surveyor had to complete a questionnaire for each participat-
ing resident. The questionnaire was similar to the form used during the 2011 survey and col-
lected among others demographic (age, gender), length of stay in the NH, autonomy in the
activities of daily living going from ‘less dependent’ (category O, A, B) to ‘highly dependent’ (cat-
egory C, CD, D), mobility (ambulant, wheelchair-bound or bedridden), incontinence (for urine
and/or faeces), disorientation in time and/or space, presence of pressure sores or other wounds,
indwelling urinary catheter use, vascular catheter use, recent surgery (last 3 months), antacid use
(proton pump inhibitors, H2 antihistamines), previously known MRSA, ESBLE, CPE, VRE car-
riage/infection (past 12 months), current and previous (past 3 months) antibiotic use and hospi-
tal stay during the past 12 months [23]. Comorbidity was evaluated using the Charlson’s
Comorbidity Index and categorized in three groups (none or mild, moderate, severe) [27].
Microbiological analysis
In each participating facility, trained local nurses performed a same-day series of sampling on
all selected residents including: (a) a collection kit containing one tube and three application
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 3 / 18
swabs for pooled sampling of nose, throat and perineum and a separate swab for a chronic
skin wound (when present) for MRSA detection (eSwab with trypticase soy broth (TSB)
enrichment broth + 2.5% NaCl, Copan, Brescia, Italy) and (b) a rectal swab for the detection of
ESBLE, CPE and VRE. Rectal swab sampling was carried out by using transport swabs in
Amies medium (Copan, Brescia, Italy). Specimens were refrigerated at 4˚C for a maximum of
48h and analysed in a central laboratory according to a previously established protocol [23].
For MRSA, enriched broth swabs were streaked onto a selective chromogenic medium
(MRSA-Select, Bio-Rad, Marnes-la-Coquette, France). Rectal swabs collected for ESBLE, CPE
and VRE were cultured on group-specific selective chromogenic agars (chromID ESBL, chro-
mID CARBA, chromID OXA-48, chromID VRE, bioMe
´rieux, France) and on a MacConkey-
medium (bioMe
´rieux, Marcy L’Etoile, France) taken as a sampling quality control. Rectal swab
specimens which did not yield any bacterial growth on the MacConkey agar were excluded
from further analysis as they were considered of poor quality. Matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry (MALDI-TOF MS) using Microflex LT (Bruker
Daltonics, Germany) based on the MALDI BioTyper database (version IVD 2.2 DB-5989
MSP) was used for bacterial identification of suspected colonies at species level.
Staphylococcus aureus. All isolates were submitted to a triplex polymerase chain reaction
(PCR) assay targeting 16S rRNA-mecA-nuc and 16S-mecC PCR. All confirmed MRSA strains
(one isolate per resident) were genotyped by spa typing and staphylococcal cassette chromo-
some mec (SCCmec) by determination of ccr and mec complexes. Multilocus Sequence Typing
(MLST) clonal complexes (CCS) were inferred from spa-types from previously conducted sur-
veys [28].
Enterobacteriaceae. All isolates of Enterobacteriaceae cultured on selective media were
subjected to antibiotic susceptibility testing (AST; including cefotaxime, ceftazidime, cefepime,
aztreonam, ertapenem, meropenem, ciprofloxacin, cotrimoxazole, amikacin and gentamicin).
AST was performed by disc diffusion method according to the recommendations of the Clini-
cal Laboratory Standards Institute (CLSI) [29]. ESBL production was confirmed by double
disc combination synergy test, and carbapenemase production by hydrolysis-based Carba NP
test [30]. Genotypic characterisation of resistance determinants was performed by multiplex
PCR assays and by DNA microarray (CT103; Check-Points, Netherlands) [31]. Clonality
among ESBL-positive K.pneumoniae strains (one isolate per resident) was assessed by Fourier
transform infrared (FTIR) spectroscopy using the IR Biotyper system (IRB; Bruker Daltonik
GmbH, Bremen, Germany). FTIR spectra were acquired following manufacturer’s instructions
and clustered as IRB-types with the average linkage algorithm using the IR Biotyper software
version 2.0 [32].
Enterococci. The susceptibility of all enterococcal isolates was performed by the Etest
(bioMe
´rieux, France). Interpretation was done according to the recommendation of the Euro-
pean Committee on Antimicrobial Susceptibility Testing (EUCAST) [33]. Multiplex PCR was
used for detection of vanA and vanB genes. Isolates were typed using MLST techniques.
Statistical analysis
Taking into account a cluster effect and an alpha level of 0.05, a sample size of 1530 residents
was initially calculated to achieve an absolute precision of estimate of ±1% with a confidence
level of 95% and an expected prevalence of 12% for MRSA, 6% for ESBLE and 0.5% for both
VRE and CPE.
Data were analysed using STATA 14.2 SE (StataCorp LP, Texas, USA). Median and inter-
quartile ranges (IQRs) were calculated for continuous variables. Prevalence of MDRO carriage
was calculated for each MDRO (number of residents with MDRO per 100 screened residents).
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 4 / 18
The calculated prevalence rates were weighted, taking into account the number of residents
actually tested in each NH, compared to the theoretical number of residents to test in each NH
in the study. Poisson distribution was used to calculate the 95% confidence intervals (95%CI).
In order to explore risk factors of MDRO carriage, odds ratios (OR) and 95%CI were calcu-
lated using logistic regression analysis. All predictors with p-value <0.10 in univariate analysis
were included in multiple logistic regression models with stepwise backward elimination of
the least significant variable until all remaining variables had p-value <0.05.
Ethics statement
The Ethical Committee of the University Hospital Centre of Namur (CHU UCL Namur;
national number B039201523615) approved the protocol of this study. The local surveyors
were responsible for seeking written informed consent from all residents participating in the
study. If the health professional judged that a resident was incapable of consenting (e.g. in case
of cognitive impairment), consent was obtained from his/her legal representative. All data
were coded in order to protect the identification of residents and NHs. Positive microbiolog-
ical results were reported to the general practitioners of the concerned residents.
Results
Participating nursing homes and residents
Twenty of the systematically selected NHs accepted to participate, i.e. nine primary selected
NHs and 11 reserve facilities. The remaining ten NHs were subsequently recruited taking into
account regional distribution, NH size and proportion of high-care beds (active/selected
recruitment). Of these NHs, one did not complete the study and was excluded from further
analysis.
In total, 1448 residents in 29 participating NHs (Flanders: [n = 16], Brussels: [n = 2], Wal-
loon region: [n = 11]) were screened for MDRO carriage. Questionnaires were completed for
1441 of 1448 screened residents. The median age of the residents was 86 years (IQR: 81–91
years) and their median length of residency in the facility was 29 months (IQR: 12–60
months). Detailed characteristics of the study population are shown in Table 1.
The general characteristics of actively recruited NHs did not significantly differ from the
randomly selected facilities (mean NH size: 114 beds versus 102 beds, proportion of high care
beds: 56.3% versus 58.3%).
Prevalence and microbiology of colonization
MDRO carriers were found in all participating facilities. In total, 1447 residents were screened
for MRSA by pooled specimens (nose/throat/perineum). In addition, samples from wound
lesions were obtained in 75 subjects (5.2%). MRSA carriage was identified in 133 residents.
The weighted mean prevalence was 9.0% [95%CI: 8.1–10.3] and ranged from 0.0% in one NH
to 21.6%.
Most isolates (n = 108, 81.8%) belonged to four hospital-associated lineages that are
endemic in Belgium: CC-45-SCCmec type IV (n = 43); CC8-SCCmec type IV (n = 27);
CC5-SCCmec type II (n = 23) and CC5-SCCmec type IV (n = 15) found in 18 (62.1%), 11
(37.9%), 5 (17.2%), 10 (34.5%) NHs, respectively (Table 2) [28]. Two MRSA isolates carried
TSST-1, while no PVL-positive isolates were detected. Two livestock-associated MRSA strains
(t011; CC-398) were isolated in NHs from the northern part of Belgium.
Twenty-five rectal swabs (1.7%) taken for screening of ESBLE, CPE and VRE carriage were
excluded because of poor sampling quality. Among the remaining 1423 screened residents,
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 5 / 18
Table 1. Characteristics of residents (n = 1441) included in a point prevalence survey conducted in 29 Belgian
nursing homes, 2015.
Characteristics Subcategory Result
Age, in years; median (IQR) [Range] 86 (81–91) [35–
109]
Female/male gender, n (%) 1084 (75.5) /
351 (24.5)
LOS of the NH residents, in months; median (IQR)
[Range]
29 (12–60) [0–
443]
Number of residents in a single bed room, n (%) 1175 (81.8)
Level of autonomy according to the modified KATZ
scale, n (%)
Category O 113 (8.0)
Category A 211 (14.8)
Category B 402 (28.3)
Category C/CD/D 696 (48.9)
Mobility level, n (%)
Ambulant 753 (54.6)
Wheelchair/bedridden 626 (45.4)
Urinary and/or faecal incontinence, n (%) 842 (62.1)
Charlson’s Comorbidity Index, n (%)
None or mild 409 (31.5)
Moderate 684 (52.7)
Severe 204 (15.7)
Previous hospitalization in the year prior to the survey, n
(%)
415 (28.9)
Previous stay in several different hospital wards in the
year prior to the survey, n (%)
17 (1.2)
Known dementia, n (%) 702 (54.1)
Known chronic obstructive pulmonary disease, n (%) 152 (11.7)
Known recurrent urinary tract infection, n (%) 109 (8.4)
Previously known MRSA colonization (past year), n (%) 42 (2.9)
Previously known MRSA colonization/infection (past
year), n (%)
48 (3.3)
Current MRSA decolonisation procedure at the time of
survey, n (%)
12 (0.8)
Previously known ESBLE colonization (past year), n (%) 23 (1.6)
Previously known ESBLE colonization/infection (past
year), n (%)
40 (2.8)
Previously known CPE colonization/infection (past year),
n (%)
2 (0.1)
Previously known VRE colonization/infection (past year),
n (%)
0 (0.0)
Wounds (pressure sores/ulcers, other wounds: surgical/
traumatic), n (%)
117 (8.2)
Urinary catheter, n (%) 26 (1.8)
Vascular catheter, n (%) 2 (0.1)
Gastrostomy, n (%) 18 (1.3)
Tracheostomy, n (%) 2 (0.1)
Naso-gastric tube feeding, n (%) 12 (0.9)
Residents with current antibiotic use (the day of the
survey), n (%)
73 (5.1)
(Continued)
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 6 / 18
164 were found to carry one ESBLE, while four residents carried two. The weighted mean
prevalence of ESBLE carriage was 11.3% [95%CI: 10.6–13.1], ranging from 0.0% in two NHs
to 45.8%.
Escherichia coli was the most frequently isolated ESBL-positive Enterobacteriaceae species
(n = 143, 83.1%), followed by Klebsiella pneumoniae (n = 29, 16.9%). The most predominant
Table 1. (Continued)
Characteristics Subcategory Result
Residents with previous antibiotic use (past 3 months), n
(%)
323 (22.4)
Total number of antibacterials prescribed for systemic use
[J01] in the past 3 months, n (%)
435 (100.0)
Tetracyclines (J01A) 15 (3.4)
Amphenicols (J01B) 2 (0.5)
Beta-lactam penicillins (J01C) 139 (32.0)
Other beta-lactams (J01D) 24 (5.5)
Sulfonamides and trimethoprim
(J01E)
18 (4.1)
Macrolides, lincosamins and
streptogrammins (J01F)
27 (6.2)
Quinolones (J01M) 85 (19.5)
Other antimicrobials (J01X) 125 (28.7)
Antacid use (proton pump inhibitors, H2 antihistamines)
at the time of screening, n (%)
622 (45.3)
NH, nursing home; LOS, length of stay; IQR, interquartile range; MRSA, methicillin-resistant Staphylococcus aureus;
ESBLE, extended-spectrum β-lactamase-producing Enterobacteriaceae; VRE, vancomycin-resistant enterococci; CPE,
carbapenemase-producing Enterobacteriaceae.
Missing values were not included in the percentage calculation
Category O = complete autonomy and Category C, CD or D = highest level of dependency
https://doi.org/10.1371/journal.pone.0214327.t001
Table 2. Molecular typing of methicillin-resistant Staphylococcus aureus (MRSA) isolates (n = 132) in 29 Belgian
nursing homes, 2015.
CC-SCCmec Most frequent spa-type(s) Number of isolates
CC5-II t003 23
CC5-IV t002 13
CC5-IV (2&5) t002 2
CC5-VI t777 12
CC8-IV t008 23
CC8-IV (2&5) t008, t2054 4
CC8-V t008 1
CC22-IV t032 3
CC45-II t038 1
CC45-IV t740 43
a
CC45-NT t330 1
CC398-V t011 2
Others (IV or V) various 4
a
NT, SCCmec non-typeable.
a
One isolate within this group carried toxic shock syndrome toxin 1 (TSST-1).
https://doi.org/10.1371/journal.pone.0214327.t002
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 7 / 18
ESBL coding genes belonged to the CTX-M family (93.0%) with a predominance of CTX-M
group 1 and especially of CTX-M-15 within this group (Fig 1).
The 143 ESBL-producing E.coli strains were widely distributed in 27 of the 29 participating
NHs with CTX-M group 1 (n = 67; 46.9%) and CTX-M group 9 (n = 41; 28.7%) as the predom-
inant ESBL enzymes found in 22 and 12 NHs, respectively.
All ESBL-positive K.pneumoniae strains harbored a CTX-M-15-like encoding gene. In two
NHs, CTX-M-15-like ESBL-producing K.pneumoniae represented more than half of all iso-
lated ESBLE strains (n = 10/17 in one NH and n = 8/15 in the other NH). Among these
CTX-M-15-like ESBL K.pneumoniae, FTIR spectroscopy clustered 9/10 isolates of the first
NH in the same partition and 7/8 isolates of the second NH in a different (unrelated) partition.
The isolates from the other NHs were determined as different IRB-types.
The co-resistance rate to ciprofloxacin and co-trimoxazole was nearly 100% in ESBL-posi-
tive K.pneumoniae and overall lower but still substantial in ESBL-positive E.coli (74.8%
(n = 107/143) resistant to ciprofloxacin and 42.0% (n = 60/143) to co-trimoxazole). A higher
co-resistance rate was associated with CTX-M type ESBL producers (88.1% (n = 141/160)
resistant to ciprofloxacin and/or co-trimoxazole) compared to other (TEM or SHV) types of
ESBLs (40.0% (n = 4/10) resistant) (Table 3).
The rate of co-colonization by MRSA and ESBLE was low (n = 27/1423; weighted mean
prevalence 1.8% [95%CI: 1.4–2.5], ranging between 0 and 13.7%). There was no significant
correlation between the prevalence of MRSA and ESBLE carriage in the participating NHs
(p = 0.21).
The prevalence of CPE and of VRE carriage was low (less than 0.1%). One resident carried
an OXA-48 carbapenemase-producing K.pneumoniae (along with a CTX-M-15-like ESBL).
Additionally, non carbapenemase-producing carbapenem resistant Enterobacteriaceae (Enter-
obacter cloacace [n = 5], K.pneumoniae [n = 3] and E.coli [n = 1]) species were isolated from
nine residents (0.6%). Only one resident carried a VRE isolate, subtyped as vanA-producing
Enterococcus faecium (ST19).
Fig 1. Distribution of ESBL-producing Enterobacteriaceae by type of enzyme (n = 172 isolates).
https://doi.org/10.1371/journal.pone.0214327.g001
Table 3. Distribution of co-resistance to ciprofloxacin and/or co-trimoxazole among extended spectrum beta-lactame (ESBL) producing Escherichia coli and Klebsi-
ella pneumoniae isolates in 29 Belgian nursing homes, 2015.
E.coli K.pneumoniae Total
Ciprofloxacin Co-trimoxazole CTX-M type Other type (TEM or SHV) Not analyzed CTX-M type
Resistant Resistant 47 1 1 28 77
Susceptible 56 1 1 1 59
Susceptible Resistant 9 2 11
Susceptible 19 6 25
Total 131 10 2 29 172
https://doi.org/10.1371/journal.pone.0214327.t003
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 8 / 18
In order to assess the occurrence of potential recruitment bias, we compared the observed
prevalence rates according to the method of recruitment (20 randomly selected NHs versus
the 9 actively recruited NHs). The prevalence of MRSA-carriers was not statistically different
between the two cohorts (randomly selected NHs: 8.3% [95%CI: 7.1–9.7] versus actively
recruited NHs: 11.0% [95%CI: 8.9–13.4], p = 0.10). On the other hand, the prevalence of
ESBLE carriage was significantly higher in the group of actively recruited NHS (14.8% [95%
CI: 12.4–17.5] compared to the randomly selected NHs (10.4% [95%CI: 9.1–12.0], p = 0.02).
Risk factor analysis
Significant risk factors of MRSA and ESBLE carriage in univariate analysis (p<0.05) are pre-
sented in Table 4.
Using multiple logistic regression (Table 5), the best predictors of being colonized by
ESBLE were impaired mobility (being wheelchair bound or bedridden), recent antimicrobial
treatment (within the past 3 months) with fluoroquinolones (J01MA) or with combinations of
sulphonamides and trimethoprim, including derivatives (J01EE) and ongoing use of antacids
(proton pump inhibitors, H2 antihistamines). The latter was also found to be a predictor of
MRSA carriage, in addition to previously known carriage/infection with MRSA (past 12
months), use of nitrofuran derivatives (J01XE) in the past 3 months and a stay in several differ-
ent hospital wards in the past year.
Table 4. Risk factors for colonization with MRSA and ESBLE among a random sample of residents screened within 29 Belgian nursing homes, 2015: Results from
univariate analysis.
Predictors
a
MRSA carriers (n = 133/1447) ESBLE carriers (n = 168/1423)
Unadjusted OR (95%CI);
p-value
Unadjusted OR (95%CI); p-value
Gender (male) 0.67 (0.44–1.01); 0.055
Modified Katz score C, CD or D (highly dependent) 1.70 (1.10–2.62); 0.002
Mobility (wheelchair bound or bedridden) 1.76 (1.26–2.46); 0.001
Urinary and/or faecal incontinence 1.54 (1.06–2.23); 0.022
Pressure sore or skin ulcer 2.35 (1.27–4.36); 0.007
Recurrent urinary tract infections 1.74 (1.04–2.92); 0.035
Antacid use (proton pump inhibitors, H2 antihistamines) 1.57 (1.09–2.26); 0.016 1.90 (1.35–2.66); <0.001
Previously known MRSA carriage/infection4.15 (2.18–7.92); <0.001
Previously known ESBLE carriage/infection2.55 (1.15–5.65); 0.021
Previous antibiotic use (past 3 months) 2.14 (1.52–3.02); <0.001
3 antibiotics in the past 3 months 3.69 (1.57–8.69); 0.003
Previous antibiotic use with:
Penicillins with extended spectrum (J01CA) 2.31 (1.03–5.16); 0.042
Beta-lactamase resistant penicillins (J01CF) 5.10 (0.85–30.72); 0.076
Combinations of sulphonamides and trimethoprim, including derivatives (J01EE) 6.10 (2.24–16.61); <0.001
Fluoroquinolones (J01MA) 1.81 (0.95–3.43); 0.071 2.73 (1.60–4.66); <0.001
Nitrofuran derivatives (J01XE) 2.53 (1.27–5.02); 0.008
Other antibacterials (J01XX) 2.19 (1.03–4.68); 0.042
Hospital stay (last year) in several different hospital wards 4.22 (1.05–16.95); 0.008
MRSA, methicillin-resistant Staphylococcus aureus; ESBLE, extended-spectrum β-lactamase-producing Enterobacteriaceae
a
Only predictors with a p-value <0.10 in univariate analysis are reported in this table.
‘previous known MRSA or ESBLE carriage/infection’ = the resident has antecedents of MRSA or ESBLE carriage/infection (past year).
Classification according to WHO ATC system (http://www.whocc.no/atc_ddd_index/)
https://doi.org/10.1371/journal.pone.0214327.t004
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 9 / 18
Discussion
In this multicentre study, the mean weighted prevalence of asymptomatic MRSA and ESBLE
carriage among NH residents was 9.0% and 11.3%, respectively. Only one CPE and one VRE
carrier were found (prevalence less than 0.1%).
Over the past decades, several studies (mainly point prevalence surveys) have been con-
ducted to explore MDRO carriage/infection in European LTCFs [2]. When interpreting and
comparing the results and outcomes of these studies, not only methodological variabilities
(e.g. differences in applied microbiological methods, in screened sampling sites or in criteria
for the focused MDROs) should be considered but also selection criteria such as the type of
LTCF in which the study is conducted. LTCFs represent a very large scope of facilities (from
residential care to sub-acute LTCFs), with important variations in medical and social services
provided, length of stay, population case-mix, organizational structure and available resources
[34]. In addition to the variations in the epidemiology of antimicrobial resistance, differences
in methodology and study setting can probably also account in part for the large inter-country
variations.
For the third time in Belgium, we explored asymptomatic MRSA carriage among NH resi-
dents using a comparable methodology. The mean weighted prevalence of asymptomatic
MRSA carriage significantly decreased between 2005 (19.5%; 95%CI: 16.4–21.5) and 2011
(12.2%; 95%CI: 11.3–13.1) and continued to drop to 9.0% (95%: 8.1–10.3) in 2015 [22,23]. A
similar downward trend was observed in the mandatory surveillance of MRSA in acute care
hospitals in Belgium where the incidence decreased from 4.0 hospital-acquired MRSA cases
per 1000 admissions in 2003 to 1.1 cases per 1000 admissions in 2015 (annual decrease of 0.23
cases per 1000 admission, p<0.001) [35]. Since the late 1990s, several initiatives have been
implemented in order to limit the spread of MRSA in healthcare facilities in Belgium, includ-
ing the publication and updates of national guidelines for the control of transmission of
MRSA in acute and chronic care sectors [36–39], repeated national campaigns in order to pro-
mote hand hygiene in hospitals [40,41] and national initiatives in order to rationalize antimi-
crobial use both in acute care and in the community [42,43].
The implementation of all these multifaceted interventions contributed to the decrease in
the incidence of MRSA among hospitalized patients as well to the decrease in the prevalence of
Table 5. Multiple logistic regression analysis of individual risk factors for carriage of MRSA (3A), of ESBLE (3B)
among a random sample of residents screened within 29 Belgian nursing homes, 2015.
3A: Predictors for MRSA carriage Adjusted OR
(95%CI)
p-value
Previously known MRSA carriage/infection (past 12 months) 3.77 (1.91–7.45) <0.001
Previous use of nitrofuran derivatives (J01XE; past 3 months) 2.25 (1.11–4.55) 0.024
Recent stay in several different hospital wards (past 12 months) 3.99 (1.24–12.81) 0.020
Current antacid use (proton pump inhibitors, H2 antihistamines) 1.49 (1.03–2.16) 0.034
3B: Predictors for ESBLE carriage Adjusted OR (95%
CI)
p-
value
Mobility (wheelchair bound or bedridden) 1.60 (1.11–2.30) 0.011
Previous use of fluoroquinolones (J01MA; past 3 months) 2.60 (1.48–4.55) 0.001
Previous use of combinations of sulphonamides and trimethoprim, including
derivatives (J01EE; past 3 months)
5.40 (1.94–15.07) 0.001
Current antacid use (proton pump inhibitors, H2 antihistamines) 1.74 (1.22–2.48) 0.002
MRSA = methicillin-resistant Staphylococcus aureus; ESBLE = extended-spectrum β-lactamase-producing
Enterobacteriaceae
https://doi.org/10.1371/journal.pone.0214327.t005
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 10 / 18
MRSA carriage in NH residents, but has not been successful in curbing the evolution of multi-
drug resistance in Gram-negative bacteria in Belgian care facilities. The prevalence of asymp-
tomatic ESBLE carriage among NH residents almost doubled between 2011 and 2015, i.e. 6.2%
(95%CI: 5.6–6.9) to 11.3% (95%CI: 10.6–13.1). In parallel, the surveillance of multidrug resis-
tant Gram-negative bacteria in Belgian acute care hospitals showed a steadily increasing inci-
dence of ESBLE colonization and infection over the last decade: from 2.2 cases per 1000
admissions in 2005 to 7.1 cases in 2015 for E.coli and from 0.7 to 3.2 cases per 1000 admissions
for K.pneumonia [35]. In both healthcare facility types, E.coli remains the most frequently
encountered ESBLE, but the proportion of K.pneumoniae among ESBLE considerably
increased between 2011 (n = 10/205; 4.9%) and 2015 (n = 29/172; 16.9%) in NHs [23]. This
constitutes an alarming evolution owing to the subsequent risk for the development of invasive
infections in colonized patients and the higher potential of K.pneumoniae to cause outbreaks
in hospitals and NHs.
Regarding the principal ESBL types circulating in the participating NHs, our results are in
line with previous studies conducted in Belgium and in other European countries indicating
that the CTX-M types, mostly CTX-M group 1 (and with CTX-M-15 largely predominant
within this group), have continued to disseminate widely in E.coli and in K.pneumoniae spe-
cies and are now almost completely replacing the SHV- and TEM-type ESBLs [44,45]. In the
two NHs with high prevalence of CTX-M-15-like-producing K.pneumoniae, the identification
of two independent clusters confirmed by typing with MALDI-TOF FTIR spectroscopy
strongly suggested local ESBLE clonal cross-transmission. Although an important ESBLE
inflow from a nearby acute care hospital was reported in one of these two NHs (KL, personal
communication with the concerning hospital and NH), the occurrence of local transmission is
also supported by the fact that several of the carriers were not recently hospitalized.
While in the past five years, nosocomial VRE and CPE outbreaks have been reported in sev-
eral Belgian acute care hospitals, our study showed very low numbers of NH residents colo-
nized by these MDROs [23]. The same was observed in another prevalence study which found
no CPE colonization in Belgian NH residents [46]. A possible explanation for the low CPE and
VRE colonization rates might be the overall lower use of antimicrobial agents in our NHs. In
the present study, 5.1% of the participating residents received an antimicrobial on the day of
the survey. This prevalence is significantly lower than the 28.9% found in the point prevalence
study of healthcare-associated infections and antimicrobial use conducted in 2011 in Belgian
acute care hospitals [47]. Also the spectrum of antimicrobials prescribed in NHs is very differ-
ent compared to acute care hospitals in Belgium. Parenterally administered drugs such as
cephalosporins, carbapenems, glycopeptides or aminoglycosides are only being prescribed
very infrequently in NHs residents [48].
In the present study, previous use (past 3 months) of nitrofuran derivatives was identified
as a predictor for MRSA carriage, while previous use of fluoroquinolones and combinations of
sulphonamides and trimethoprim were risk factors for ESBLE in the multivariable analysis. In
2005, MRSA carriage was linked to recent use of fluoroquinolone use and amoxicillin and cla-
vulanic acid [22]. In 2011, recent antibiotic use in general was a risk factor for ESBLE carriage,
but not for MRSA [23]. Several other studies also found ‘recent antimicrobial use’ as risk factor
for MDRO carriage/infection in NHs [2,49–51].
In the literature, recent hospital stay is also frequently mentioned as a risk factor for MRSA
carriage [2,52,53]. The same was found in the multivariable analysis of our present survey,
especially when admitted in several different hospital wards, and in the 2005 study [22].
In Belgium, acute care hospitals and NHs seem to act as ‘communicating vessels’ at least for
MRSA and for ESBLE as exemplified by the parallel increasing/decreasing trends and observed
ESBL enzyme types and MRSA spa types in both types of care facilities [22]. Transmission of
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 11 / 18
MDROs is facilitated by frequent transfers of patients/residents between chronic and acute
care sectors. In the present study, 28.9% of the NH residents had been admitted to an acute
care hospital at least once in the past 12 months.
Bed shortages and bed management strategies are leading to an increasing number of
patient transfers between hospital wards. A recent study with retrospective analysis of hospital
data showed that 10 000 patients were moved 34 715 times in one year which equates to an
average of 2.4 transfers per patient [54]. During hospitalization, NH residents can be colonized
with MDROs endemic in the different wards, facilitating the dissemination of these organisms
when returning to the NH. Characteristics of the NH and its resident population can contrib-
ute to an increasing risk for colonization/infection with MDROs. Compared to acute care hos-
pitals, NHs are ‘home replacing environments’ where residents have frequent social/care
contacts with healthcare staff and other residents. Furthermore, the workload is often very
important and NH staff generally have less experience in mastering infection control and
(hand)hygiene practices [55,56]. NHs can become reservoirs, subsequently leading to an
increasing MDRO inflow in acute care hospitals. In order to interrupt this vicious circle, an
appropriate communication between facilities during transfer as well as implementation of
well-coordinated screening policies are urgently needed in both acute and long-term care.
Colonization history by the same microorganism was identified as risk factor for both
MRSA and ESBLE in different studies conducted across Europe [2]. In both the current study
and the 2011 survey, previously known MRSA carriage/infection (past 12 months) was associ-
ated with higher risk for MRSA carriage at the time of the study. However, in contrast to 2011
a history of ESBLE carriage was no longer a predictor for ESBLE in the present study [23].
Physical disability and low functional status are often associated with an increased risk for
the acquisition of MDROs as these residents require more nursing and/or medical care and
therefore have more frequent contacts with healthcare workers [2,7]. Indeed, in this study we
found impaired mobility to be associated with an increased risk for ESBLE carriage, but not
for MRSA. This matches exactly to our findings in the 2011 study [23]. In the first national
study (2005) impaired mobility was a significant risk factor for MRSA carriage [22].
In our previous study, we were surprised to see recent/current intake of gastric antacid
agents (proton-pump inhibitors or anti-H2 blockers) as a significant risk factor for MRSA car-
riage [23]. Risk analysis in the current study again indicated antacid use as a risk factor for
MRSA, but this time also for ESBLE. While the use of antacids is a well-known risk factor for
Clostridium difficile associated disease, only few studies describe antacid use as a risk factor for
ESBLE carriage in the community [57] and in the hospital setting [58–60]. A plausible explana-
tion for the association between antacid use and ESBLE colonisation is the mechanism of a dis-
rupted barrier due to an increased gastric pH (functionality of the gastric barrier) and
therefore diminished defence system. Antacids such as PPIs are modifying the gut microbiota
[61]. In a recent study, analysis of the gut microbiome composition in a large number of indi-
viduals revealed major differences in microbiota composition in PPI users versus non-users
[62]. PPI use was associated with a significant decrease in Shannon’s diversity and with
changes in 20% of the bacterial taxa. In PPI users, the investigators observed a significant
increase in bacteria: genera Enterococcus,Streptococcus,Staphylococcus and the potentially
pathogenic species E.coli. The risk of antacid use is particularly important, because antacids
are widely used in Belgian NHs (45.3% of all participating NH residents in this study).
Other risk factors such as a long length of study, history of invasive procedures/devices,
pressure sore/ulcers and underlying pathologies/comorbidities that are frequently reported in
the literature to be associated with MDRO carriage in NH residents, were not found in our
study [2].
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 12 / 18
We do acknowledge that this study had several limitations. First, the study design (point
prevalence survey) did not allow us to investigate more in detail the dynamics of MDRO colo-
nization (acquisition, persistence and clearance of carriage). Therefore, follow-up studies
would have been needed, but these investigations were no aims of our study. A second limita-
tion is that roughly one third of the participating NHs were actively recruited, taking into
account the geographic location, NH size and proportion of high-skilled beds from the ran-
domly selected NHs they replaced. A higher prevalence of ESBL carriage was observed in the
actively recruited NHs (14.8%) compared to the randomly selected NHs (10.4%, p = 0.02). The
reasons accounting for the higher prevalence of ESBLE in this subgroup of institutions could
not be elucidated. Further and in comparison to the previous two national surveys, we no lon-
ger presented data by region as we only aimed to have representative data at national level.
Despite these limitations, we believe this study is of interest because in contrast to most
other European multicentre point prevalence studies it provided simultaneously data for car-
riage of MRSA, ESBLE, VRE and CPE in NHs. Since we used a comparable methodology
throughout the three surveys, we have been able to closely monitor the evolution of MDRO
carriage in our Belgian NHs over a decade. The data were also useful for increasing awareness
and fostering the implementation of programs aiming to improve infection control and anti-
microbial stewardship in LTCFs at national level. Moreover, the prevalence data and identified
risk factors have been of added value for training of healthcare personnel at the NH level.
Conclusions
The results of the present survey and of the two previous studies provided valuable insight in
the evolution of MDRO in LTCFs. The decreasing trend in MRSA carriage and increasing
trend in ESBLE carriage among our NH residents are in line with the evolution of the MRSA
and ESBL surveillance data in Belgian acute care hospitals. This confirms that acute and
chronic care facilities (including NHs) can act as communicating vessels and therefore require
a ‘systemic’ approach. Improvement of communication and inter-facility transfer policies
between these two sectors are urgently needed. Additional efforts to enhance the compliance
to standard precautions including personal hygiene, hand hygiene and environmental hygiene
as well as antimicrobial stewardship programs in NHs are needed in order to stop the acquisi-
tion and transmission of MDROs in healthcare facilities.
Acknowledgments
This study was organized with the support of the Belgian Antibiotic Policy Coordination Com-
mittee. We thank all colleagues from nursing homes for their diligent participation in this
study:
Europasquare (Deurne), WZC Stede Akkers (Hoogstraten), Les Bruyères Sur Senne
(Tubize), Re
´sidence Birmingham (Bruxelles), Se
´niorie d’Evere (Bruxelles), Les Glycines (Her-
seaux), Re
´sidence Le Chalon (Chimay), Nouvelle Re
´sidence de la Fontaine (Leval-Trahegnies),
Home du Moulin àCailloux (Tournai), Re
´sidence Regina (Moresnet), Au Vert Bocage (Lon-
cin), Re
´sidence ST-Joseph (Verviers), M.R. Saint-Joseph (Blegny), Huize Sint-Jozef (Nieuwer-
kerken), M.R.S. Saint Antoine (Saint-Mard), Re
´sidence Sainte-Anne (Dinant), WZC De
Boomgaard (Lembeke), WZC Tehuis De Mey (Wachtebeke), WZC Hof Ter Veldeken (Leb-
beke), WZC Seniorencentrum Het Lindeken (Merelbeke), WZC Ter Durme (Lokeren), WZC
Parkhof (Machelen), Sint Antonius (Sint-Pieters-Leeuw), Huize Maria Troost (Veurne), WZC
Ter Berken (Roeselare), Sint-Bernardus (De Panne), WZC Marialove (Heestert).
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 13 / 18
Author Contributions
Conceptualization: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Olivier Denis, Didier
Schoevaerdts, Youri Glupczynski.
Data curation: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Catherine Berhin, Pierre
Bogaerts, Audrey Noel, Claire Nonhoff, Katherine Loens.
Formal analysis: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Audrey Noel, Magali Dode
´-
mont, Olivier Denis, Margareta Ieven, Didier Schoevaerdts, Boudewijn Catry, Youri
Glupczynski.
Investigation: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Catherine Berhin, Pierre
Bogaerts, Audrey Noel, Claire Nonhoff, Katherine Loens.
Methodology: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Olivier Denis, Didier Schoe-
vaerdts, Youri Glupczynski.
Resources: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Catherine Berhin, Pierre Bogaerts,
Audrey Noel, Claire Nonhoff, Magali Dode
´mont, Olivier Denis, Margareta Ieven, Kather-
ine Loens, Didier Schoevaerdts, Boudewijn Catry, Youri Glupczynski.
Writing – original draft: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Magali Dode
´mont,
Olivier Denis, Margareta Ieven, Didier Schoevaerdts, Boudewijn Catry, Youri Glupczynski.
Writing – review & editing: Katrien Latour, Te-Din Huang, Be
´atrice Jans, Audrey Noel,
Magali Dode
´mont, Olivier Denis, Margareta Ieven, Katherine Loens, Didier Schoevaerdts,
Boudewijn Catry, Youri Glupczynski.
References
1. Cohen ML. Changing patterns of infectious disease. Nature 2000; 406: 762–767. https://doi.org/10.
1038/35021206 PMID: 10963605
2. Aschbacher R, Pagani E, Confalonieri M, Farina C, Fazii P, Luzzaro F, et al. Review on colonization of
residents and staff in Italian long-term care facilities by multidrug-resistant bacteria compared with other
European countries. Antimicrob Resist Infect Control 2016; 5: 33. pii: 136. https://doi.org/10.1186/
s13756-016-0136-1 PMID: 27766146
3. Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, Moses AE. Vancomycin-resistant enterococci in
long-term care facilities. Infect Control Hosp Epidemiol 2009; 30: 786–789. https://doi.org/10.1086/
598345 PMID: 19591581
4. Cunha CB, Kassakian SZ, Chan R, Tenover FC, Ziakas P, Chapin KC, et al. Screening of nursing home
residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospi-
tals: Incidence and risk factors. Am J Infect Control 2016; 44: 126–130. pii: S0196-6553(15)00992-X.
https://doi.org/10.1016/j.ajic.2015.09.019 PMID: 26631643
5. El Eman K, Arbuckle L, Essex A, Samet S, Eze B, Middleton G, et al. Secure surveillance of antimicro-
bial resistant organism colonization or infection in Ontario long term care homes. PLoS One 2014; 9:
e93285. pii: PONE-D-13-19421. https://doi.org/10.1371/journal.pone.0093285 PMID: 24714643
6. Elizaga ML, Weinstein RA, Hayden MK. Patients in long-term care facilities: a reservoir for vancomycin-
resistant enterococci. Clin Infect Dis 2002; 34: 441–446. pii: CID010272. https://doi.org/10.1086/
338461 PMID: 11797169
7. Giufre M, Ricchizzi E, Accogli M, Barbanti F, Monaco M, Pimentel de AF, et al. Colonization by multi-
drug-resistant organisms in long-term care facilities in Italy: a point-prevalence study. Clin Microbiol
Infect 2017; 23: 961–967. pii: S1198-743X(17)30211-2. https://doi.org/10.1016/j.cmi.2017.04.006
PMID: 28412380
8. Gruber I, Heudorf U, Werner G, Pfeifer Y, Imirzalioglu C, Ackermann H, et al. Multidrug-resistant bacte-
ria in geriatric clinics, nursing homes, and ambulant care—Prevalence and risk factors. Int J Med Micro-
biol 2013; 303: 405–409. pii: S1438-4221(13)00066-0. https://doi.org/10.1016/j.ijmm.2013.05.002
PMID: 23770266
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 14 / 18
9. Lin MY, Lyles-Banks RD, Lolans K, Hines DW, Spear JB, Petrak R, et al. The importance of long-term
acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing
Enterobacteriaceae. Clin Infect Dis 2013; 57: 1246–1252. pii: cit500. https://doi.org/10.1093/cid/cit500
PMID: 23946222
10. Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. Colonisation with ESBL-producing
and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-
resistant Staphylococcus aureus in a long-term care facility over one year. BMC Infect Dis 2015; 15:
168. pii: 10.1186/s12879-015-0880-5. https://doi.org/10.1186/s12879-015-0880-5 PMID: 25887288
11. McKinnell JA, Miller LG, Singh R, Kleinman K, Peterson EM, Evans KD, et al. Prevalence of and Factors
Associated With Multidrug-Resistant Organism (MDRO) Colonization in 3 Nursing Homes. Infect Con-
trol Hosp Epidemiol 2016; 37: 1485–1488. pii: S0899823X16002154. https://doi.org/10.1017/ice.2016.
215 PMID: 27671022
12. O’Fallon E, Schreiber R, Kandel R, D’Agata EM. Multidrug-resistant gram-negative bacteria at a long-
term care facility: assessment of residents, healthcare workers, and inanimate surfaces. Infect Control
Hosp Epidemiol 2009; 30: 1172–1179. pii: S0195941700038017. https://doi.org/10.1086/648453
PMID: 19835474
13. Rooney PJ, O’Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, et al. Nursing homes as a
reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia
coli. J Antimicrob Chemother 2009; 64: 635–641. pii: dkp220. https://doi.org/10.1093/jac/dkp220 PMID:
19549667
14. Ruiz-Garbajosa P, Hernandez-Garcia M, Beatobe L, Tato M, Mendez MI, Grandal M, et al. A single-day
point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex
clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae. J Antimicrob
Chemother 2016; 71: 348–352. pii: dkv355. https://doi.org/10.1093/jac/dkv355 PMID: 26518051
15. Stuart RL, Kotsanas D, Webb B, Vandergraaf S, Gillespie EE, Hogg GG, et al. Prevalence of antimicro-
bial-resistant organisms in residential aged care facilities. Med J Aust 2011; 195: 530–533. pii:
stu10724_fm. PMID: 22060088
16. Bonomo RA. Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in
the practice of infectious diseases. Clin Infect Dis 2000; 31: 1414–1422. pii: CID000639. https://doi.org/
10.1086/317489 PMID: 11096012
17. Van den Dool C, Haenen A, Leenstra T, Wallinga J. The role of nursing homes in the spread of antimi-
crobial resistance over the healthcare network. Infect Control Hosp Epidemiol 2016; 37: 761–767. pii:
S0899823X16000593. https://doi.org/10.1017/ice.2016.59 PMID: 27052880
18. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000; 31: 752–756. pii:
CID000574. https://doi.org/10.1086/314010 PMID: 11017825
19. Bradley SF. Issues in the management of resistant bacteria in long-term-care facilities. Infect Control
Hosp Epidemiol 1999; 20: 362–366. pii: ICHE7371. https://doi.org/10.1086/501637 PMID: 10349960
20. Cassone M, Mody L. Colonization with Multi-Drug Resistant Organisms in Nursing Homes: Scope,
Importance, and Management. Curr Geriatr Rep 2015; 4: 87–95. https://doi.org/10.1007/s13670-015-
0120-2 PMID: 25664233
21. Harrison EM, Ludden C, Brodrick HJ, Blane B, Brennan G, Morris D, Coll F, et al. Transmission of meth-
icillin-resistant Staphylococcus aureus in long-term care facilities and their related healthcare networks.
Genome Med 2016; 8: 102. pii: 10.1186/s13073-016-0353-5. https://doi.org/10.1186/s13073-016-
0353-5 PMID: 27716432
22. Denis O, Jans B, Deplano A, Nonhoff C, De Rijck R, Suetens C, et al. Epidemiology of methicillin-resis-
tant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Che-
mother 2009; 64: 1299–1306. pii: dkp345. https://doi.org/10.1093/jac/dkp345 PMID: 19808236
23. Jans B, Schoevaerdts D, Huang TD, Berhin C, Latour K, Bogaerts P, et al. Epidemiology of multidrug-
resistant microorganisms among nursing home residents in Belgium. PLoS One 2013; 8: e64908. pii:
PONE-D-13-09449. https://doi.org/10.1371/journal.pone.0064908 PMID: 23738011
24. Conseil supe
´rieur de la Sante
´. Mesures àprendre suite àl’e
´mergence des ente
´robacte
´ries productrices
de carbape
´ne
´mases (CPE) en Belgique (CSS 8791). Federal public service health, food chain safety
and environment website;2012. Available: https://www.health.belgium.be/fr/avis-8791-cpe. Accessed
2018 November 26.
25. Jans B, Glupczynsk Y, Denis O. Surveillance des bacte
´ries re
´sistantes aux antibiotiques dans les ho
ˆpi-
taux Belges: Rapport annuel 2012. Brussels: Scientific Institute of Public Health;2013. IPH/EPI Reports
Nr 2013–037: Available: http://www.nsih.be/download/MRSA/MRSA_ESBL_CPE_Y2015/RAPPORT_
AMR_Y2015_FR.pdf. Accessed 2018 November 26
26. Prabaker K, Lin MY, McNally M, Cherabuddi K, Ahmed S, Norris A, et al. Transfer from high-acuity
long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 15 / 18
producing Enterobacteriaceae: a multihospital study. Infect Control Hosp Epidemiol 2012; 33:1193–9.
https://doi.org/10.1086/668435 PMID: 23143355
27. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity
in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373–383. PMID: 3558716
28. Argudin MA, Dodemont M, Taguemount M, Roisin S, de Mendonc¸a R, Deplano A, et al. In vitro activity
of ceftaroline against clinical Staphylococcus aureus isolates collected during a national survey con-
ducted in Belgian hospitals. J Antimicrob Chemother 2017; 72: 56–59. pii: dkw380. https://doi.org/10.
1093/jac/dkw380 PMID: 27634917
29. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibil-
ity testing: twenty-fifth informational supplement M100-S25. Wayne, PA, USA: CLSI, 2015.
30. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae.
Emerg Infect Dis 2012; 18: 1503–1507. https://doi.org/10.3201/eid1809.120355 PMID: 22932472
31. Bogaerts P, Rezende de Castro R, de Mendonc¸a R, Huang TD, Denis O, Glupczynski Y. Validation of
carbapenemase and extended-spectrum beta-lactamase multiplex endpoint PCR assays according to
ISO 15189. J Antimicrob Chemother 2013; 68: 1576–1582. pii: dkt065. https://doi.org/10.1093/jac/
dkt065 PMID: 23508620
32. Dinkelacker AG, Vogt S, Oberhettinger P, Mauder N, Rau J, Kostrzewa M et al. Typing and species
identification of clinical Klebsiella isolates by Fourier-transform infrared spectroscopy and matrix-assis-
ted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2018;56. pii:
JCM.00843-18. https://doi.org/10.1128/JCM.00843-18 PMID: 30135233
33. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpre-
tation of MICs and zone diameters. Version 5.0, 2015. http://www.eucast.org.
34. Moro ML, Jans B, Cookson B, Fabry J. The burden of healthcare-associated infections in European
long-term care facilities. Infect Control Hosp Epidemiol;2010: Suppl 1: S59–62. https://doi.org/10.1086/
655989 PMID: 20929373
35. Jans B, Glupczynsk Y, Goossens H, Denis O. Surveillance des bacte
´ries re
´sistantes aux antibiotiques
dans les ho
ˆpitaux Belges: Rapport annuel 2015. Brussels: Scientific Institute of Public Health;2016.
IPH/EPI Reports Nr 2016–020: ISSN Nr 2466–7935. Available: http://www.nsih.be/download/MRSA/
MRSA_ESBL_CPE_Y2015/RAPPORT_AMR_Y2015_FR.pdf. Accessed 2017 December 11
36. Belgian Infection Control Society. De
´tection, surveillance, pre
´vention et contro
ˆle de la transmission
d’ente
´robacte
´ries productrices de BLSE: recommandations et re
´ponse à60 questions pratiques. BICS
website;2008:1–35. Available: http://www.belgianinfectioncontrolsociety.be/v2/accueil/algemene-2/
esb/. Accessed 2017 December 11.
37. Conseil supe
´rieur de la Sante
´. Recommandations en matière de pre
´vention, maı
ˆtrise et prise en charge
des patients porteurs de bacte
´ries multi-re
´sistantes aux antibiotiques (MDRO) dans les institutions de
soins (CSS 9277): Avis interme
´diaire Version provisoire soumise aux professionnels de terrain (plate-
formes d’hygiène hospitalière) en vue d’une ame
´lioration (planifie
´e pour mai 2018). Federal public ser-
vice health, food chain safety and environment website;2017. Available: https://www.health.belgium.be/
fr/avis-9277-mdro. Accessed 2018 January 8.
38. GDEPIH-GOSPIZ. Recommendations pour le contro
ˆle et la pre
´vention de la transmission de Staphylo-
coccus Aureus Re
´sistant àla Me
´thicilline dans les ho
ˆpitaux belges. BICS Website;2003:1–28. Avail-
able: http://www.belgianinfectioncontrolsociety.be/v2/files/9613/8213/0376/MRSAFR2005.pdf.
Accessed 2017 December 11.
39. GDEPIH-GOSPIZ. Mesures pre
´ventives de la transmission de Staphylococcus aureus re
´sistant àla
Me
´thicilline (MRSA) dans les maisons de repos et de soins (MRS). BICS website;2005. Available:
http://www.belgianinfectioncontrolsociety.be/v2/files/9013/8213/0377/MRSAMRS.pdf. Accessed 2017
December 11.
40. Fonguh S, Uwineza A, Catry B, Simon A. Belgian hand hygiene campaigns in ICU, 2005–2015. Arch
Public Health 2016; 74: 47. pii: 159. https://doi.org/10.1186/s13690-016-0159-3 PMID: 27826443
41. Fonguh S, Catry B. Re
´sultats de la 6e campagne nationale pour la promotion de l’hygiène des mains
dans les ho
ˆpitaux 2014–2015. Brussels: Scientific Institute of Public Health;2015. IPH/EPI Reports Nr
2015–54: Depot Nr D/2015/2505/80. Available: http://www.nsih.be/surv_hh/download/R%C3%
A9sultats%20nationaux%202014-2015.pdf. Accessed 2017 December 11.
42. Belgian Antibiotic Policy Coordination Committee. Guide belge des traitements anti-infectieux en pra-
tique ambulatoire: e
´dition 2012. Federal public service health, food chain safety and environment web-
site;2017. Available: http://consultativebodies.health.belgium.be/sites/default/files/documents/2012_
guide_belge_traitement_anti_infectieux_pratique_ambulatoire_antibioticagids_fr.pdf. Accessed 2017
December 11.
43. Belgian Antibiotic Policy Coordination Committee. Recommandations de traitements anti-infectieux en
milieu hospitalier: BAPCOC-SBIMC. Federal public service health, food chain safety and environment
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 16 / 18
website;2017. Available: http://organesdeconcertation.sante.belgique.be/sites/default/files/documents/
bapcoc_guidelineshospi_2017_sbimc-bvikm_fr_v1.pdf. Accessed 2017 December 11.
44. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing
the face of ESBLs in Europe. J Antimicrob Chemother 2007; 59: 165–174. pii: dkl483. https://doi.org/10.
1093/jac/dkl483 PMID: 17158117
45. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, Montesinos I, et al. Trends in
production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest:
results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 2011; 66: 37–47. pii:
dkq388. https://doi.org/10.1093/jac/dkq388 PMID: 21036771
46. Saegeman VS, Ntoumpanaki M, Niclaes L, Schuermans A. Carbapenemase producing Enterobacteria-
ceae in Belgian nursing homes: myth or real danger? Acta Clin Belg 2014; 69: 30–32. https://doi.org/10.
1179/0001551213Z.00000000013 PMID: 24635396
47. European Centre for Disease Prevention and Control. Point prevalence survey of healthcare associated
infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC;2013. Available:
https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/healthcare-associated-
infections-antimicrobial-use-PPS.pdf. Accessed 2017 December 11.
48. Ben Abdelhafidh L, Latour K. Les infections lie
´es aux soins et l’usage d’antimicrobiens en maison de
repos et de soins en Belgique: Re
´sultats de l’e
´tude de pre
´valence ponctuelle HALT-3 (septembre–
Novembre 2016). Brussels: Scientific Institute of Public Health;2017. IPH/EPI Reports Nr 2017–015:
Depot Nr D/2017/2505/16. Available: http://www.nsih.be/download/LTCF/Rapport/HALT-3_Nat%
20Rapport_FR_V3.pdf. Accessed 2018 January 24.
49. Ben-Ami R, Rodriguez-Bano J, Arslan H, Pitout JD, Quentin C, Calbo ES, et al. A multinational survey
of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in
nonhospitalized patients. Clin Infect Dis 2009; 49: 682–690. https://doi.org/10.1086/604713 PMID:
19622043
50. Flokas ME, Alevizakos M, Shehadeh F, Andreatos N, Mylonakis E. Extended-spectrum beta-lacta-
mase-producing Enterobacteriaceae colonisation in long-term care facilities: a systematic review and
meta-analysis. Int J Antimicrob Agents 2017; 50: 649–656. pii: S0924-8579(17)30295-9. https://doi.org/
10.1016/j.ijantimicag.2017.08.003 PMID: 28782707
51. Zhao SY, Zhang J, Zhang YL, Wang YC, Xiao SZ, Gu FF, et al. Epidemiology and risk factors for faecal
extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) carriage derived from
residents of seven nursing homes in western Shanghai, China. Epidemiol Infect 2016; 144: 695–702.
pii: S0950268815001879. https://doi.org/10.1017/S0950268815001879 PMID: 26260355
52. Garazi M, Edwards B, Caccavale D, Auerbach C, Wolf-Klein G. Nursing homes as reservoirs of MRSA:
myth or reality? J Am Med Dir Assoc 2009; 10: 414–418. pii: S1525-8610(09)00092-9. https://doi.org/
10.1016/j.jamda.2009.02.014 PMID: 19560719
53. Vovko P, Retelj M, Cretnik TZ, Jutersek B, Harlander T, Kolman J, et al. Risk factors for colonization
with methicillin-resistant Staphylococcus aureus in a long-term-care facility in Slovenia. Infect Control
Hosp Epidemiol 2005; 26: 191–195. pii: ICHE9888. https://doi.org/10.1086/502525 PMID: 15756891
54. Blay N, Roche MA, Duffield C, Gallagher R. Intrahospital transfers and the impact on nursing workload.
J Clin Nurs 2017; 26: 4822–4829. https://doi.org/10.1111/jocn.13838 PMID: 28382638
55. Latour K. Preventie en aanpak van antibioticaresistentie in Belgische woonzorgcentra: Nationale
enquête 2012. Brussels: Belgian Infection Control Society Symposium;2012. Available: http://www.
nsih.be/download/LTCF/MDRO//MDRO_Nat%20Survey_BICS%2017nov2012.pdf Accessed 2017
December 11.
56. March A, Aschbacher R, Dhanji H, Livermore D, Bo
¨ttcher A, Sleghel F, et al. Colonization of residents
and staff of an Italian long-term care facility and an adjacent acute care hospital geriatric unit by multi-
drug-resistant bacteria. Clin Microbiol Infect 2010; 16: 934–944. https://doi.org/10.1111/j.1469-0691.
2009.03024.x PMID: 19686277
57. Reuland EA, Al Naiemi N, Kaiser AM, Heck M, Kluytmans JA, Savelkoul PH, et al. Prevalence and risk
factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam. J Antimicrob Chemother
2016; 71: 1076–1082. pii: dkv441. https://doi.org/10.1093/jac/dkv441 PMID: 26755493
58. Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Influx of
extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. Clin Infect Dis
2006; 42: 925–934. pii: CID37784. https://doi.org/10.1086/500936 PMID: 16511754
59. Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K, et al. Epidemiology and risk fac-
tors for isolation of Escherichia coli producing CTX-M-type extended-spectrum beta-lactamase in a
large U.S. Medical Center. Antimicrob Agents Chemother 2013; 57: 4010–4018. pii: AAC.02516-12.
https://doi.org/10.1128/AAC.02516-12 PMID: 23752516
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 17 / 18
60. Huizinga P, van den Bergh MK, van RM, Willemsen I, van ’t Veer N, Kluytmans J. Proton Pump Inhibitor
Use Is Associated With Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae Rectal
Carriage at Hospital Admission: A Cross-Sectional Study. Clin Infect Dis 2017; 64: 361–363. pii:
ciw743. https://doi.org/10.1093/cid/ciw743 PMID: 27965302
61. Jackson MA, Goodrich JK, Maxan ME, Freedberg DE, Abrams JA, Poole AC, et al. Proton pump inhibi-
tors alter the composition of the gut microbiota. Gut 2016; 65: 749–756. pii: gutjnl-2015-310861. https://
doi.org/10.1136/gutjnl-2015-310861 PMID: 26719299
62. Imhann F, Bonder MJ, Vich VA, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut
microbiome. Gut 2016; 65: 740–748. pii: gutjnl-2015-310376. https://doi.org/10.1136/gutjnl-2015-
310376 PMID: 26657899
Carriage of multidrug-resistant organisms in Belgian nursing homes in 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0214327 March 28, 2019 18 / 18
Available via license: CC BY 4.0
Content may be subject to copyright.
